Intimation for receipt of an Order dated 19th November 2025 issued by the Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi u/s 107 (11) of the Karnataka Goods and Services Tax Act, 2017 and the Central Goods and Services Tax Act, 2017
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Smallcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sai Life Sciences has informed the stock exchanges about receiving an order dated 19th November 2025 from the Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi under Section 107(11) of both the Karnataka Goods and Services Tax Act, 2017 and the Central Goods and Services Tax Act, 2017. This relates to a GST appeal the company had filed against an earlier tax demand. The company is required to disclose such orders received from tax authorities as per listing norms. The exact financial impact of the order, and whether it is in favour of or against the company, is not detailed in the headline.
The outcome of this GST appellate order could have a material financial impact depending on the direction of the order. Shareholders should look for the detailed filing to understand if there is any additional tax liability or if the company has received relief.